EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pronounced Reductions in Plasma Citrulline Indicate Severe Intestinal Mucosal Barrier Injury During Induction Therapy for Pediatric Acute Myeloid Leukemia

Carla Warley Kjær, Maria Ebbesen Sørum iD, Silvia De Pietri, Claus Moser, Malene Johanne Petersen, Marianne Hoffmann iD, Henrik Hasle, Sarah Weischendorff iD, Klaus Müller iD

European Journal of Haematology · 2026-11 · 117 (5) · 1275-1284

DOI: 10.1111/ejh.70267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, online erschienen am 17.07.2026. Verfasst von Carla Warley Kjær und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Citrulline, Intestinal Mucosa, Leukemia, Myeloid, Acute, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Danish Childhood Cancer Foundation, Børnecancerfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Pediatric acute myeloid leukemia (AML) chemotherapy regimens are frequently burdened by fever episodes, systemic inflammation and bloodstream infections (BSI). Mucosal barrier injury may contribute to these complications, but its role in childhood AML remains uninvestigated. This study assessed mucosal barrier injury using plasma citrulline and examined associations with inflammation, fever, and BSI.

Methods

Twenty children (1–16 years) with AML were prospectively studied during two induction courses (NOPHO‐DBH AML 2012 protocol). Plasma citrulline was measured weekly from days 1–29 of each course.

Results

All patients exhibited marked reductions in citrulline during both inductions, reaching nadir on day 15 and recovering by day 29. C‐reactive protein (CRP) levels > 50 mg/L occurred in 19/20 patients, and 10/20 developed BSI. Fever occurred in all patients during induction I and in 16/19 during induction II. Severe mucosal damage (citrulline AUC) correlated with higher CRP and more febrile days, particularly in induction II ( r s = −0.72, p = 0.0011; r s = −0.47, p = 0.06). Patients with BSI showed lower citrulline on days 22 and 29 following induction II (11.1 vs. 16.2 μM, p = 0.024) and (10.1 vs. 17.3 μM, p = 0.012).

Conclusions

Pediatric AML treatment causes significant mucosal barrier injury, which is associated with inflammatory and infectious complications and may represent a target for supportive interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CitrullineIntestinal MucosaLeukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsHumansChildChild, PreschoolAdolescentFemaleMaleInfantInduction ChemotherapyIntestinal Barrier FunctionBiomarkersC-Reactive Protein

Stichwörter der Autor:innen

AMLbloodstream infectionscitrullineinflammationintestinal mucositis

Substanzen

CitrullineBiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Department of Pediatrics, Amager and Hvidovre Hospital, Hvidovre, Denmark.
  • Department of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark.

ORCID-Profile: Maria Ebbesen Sørum, Marianne Hoffmann, Sarah Weischendorff, Klaus Müller

Förderung

  • Danish Childhood Cancer Foundation
  • Børnecancerfonden

Zitieren

APA

Kjær, C. W., Sørum, M. E., De Pietri, S., Moser, C., Petersen, M. J., Hoffmann, M., Hasle, H., Weischendorff, S., & Müller, K. (2026). Pronounced Reductions in Plasma Citrulline Indicate Severe Intestinal Mucosal Barrier Injury During Induction Therapy for Pediatric Acute Myeloid Leukemia. European Journal of Haematology, 117(5), 1275-1284. https://doi.org/10.1111/ejh.70267

Vancouver

Kjær CW, Sørum ME, De Pietri S, Moser C, Petersen MJ, Hoffmann M, et al. Pronounced Reductions in Plasma Citrulline Indicate Severe Intestinal Mucosal Barrier Injury During Induction Therapy for Pediatric Acute Myeloid Leukemia. European Journal of Haematology. 2026;117(5):1275-1284. doi:10.1111/ejh.70267

BibTeX
@article{Kjr2026,
  author = {Kjær, Carla Warley and Sørum, Maria Ebbesen and De Pietri, Silvia and Moser, Claus and Petersen, Malene Johanne and Hoffmann, Marianne and Hasle, Henrik and Weischendorff, Sarah and Müller, Klaus},
  title = {Pronounced Reductions in Plasma Citrulline Indicate Severe Intestinal Mucosal Barrier Injury During Induction Therapy for Pediatric Acute Myeloid Leukemia},
  journal = {European Journal of Haematology},
  year = {2026},
  volume = {117},
  number = {5},
  pages = {1275--1284},
  doi = {10.1111/ejh.70267}
}
Kostenlos starten →